Ann Rehabil Med.  2023 Feb;47(1):1-3. 10.5535/arm.23003.

Intrathecal Baclofen Therapy: Pros and Cons

Affiliations
  • 1Department of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea
  • 2Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea
  • 3Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
  • 4Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul, Korea
  • 5Graduate Program of Biomedical Engineering, Yonsei University College of Medicine, Seoul, Korea


Reference

1. Penn RD, Kroin JS. Intrathecal baclofen alleviates spinal cord spasticity. Lancet. 1984; 1:1078.
2. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet. 1985; 2:125–7.
3. Ethans K. Intrathecal baclofen therapy: indications, pharmacology, surgical implant, and efficacy. Acta Neurochir Suppl. 2007; 97(Pt 1):155–62.
4. Brennan PM, Whittle IR. Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Br J Neurosurg. 2008; 22:508–19.
5. Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery. 2000; 46:603–9. discussion 609-12.
6. Ueta T. [Intrathecal baclofen for severe spasticity]. Brain Nerve. 2008; 60:1415–20. Japanese.
7. Kan P, Gooch J, Amini A, Ploeger D, Grams B, Oberg W, et al. Surgical treatment of spasticity in children: comparison of selective dorsal rhizotomy and intrathecal baclofen pump implantation. Childs Nerv Syst. 2008; 24:239–43.
8. Yoon YK, Lee KC, Cho HE, Chae M, Chang JW, Chang WS, et al. Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Medicine (Baltimore). 2017; 96:e7472.
9. Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg. 2007; 107(1 Suppl):32–5.
10. Borowski A, Littleton AG, Borkhuu B, Presedo A, Shah S, Dabney KW, et al. Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop. 2010; 30:76–81.
11. Awaad Y, Rizk T, Siddiqui I, Roosen N, McIntosh K, Waines GM. Complications of intrathecal baclofen pump: prevention and cure. ISRN Neurol. 2012; 2012:575168.
12. Sgouros S, Charalambides C, Matsota P, Tsangaris I, Kostopanagiotou G. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose. Pediatr Neurosurg. 2010; 46:62–5.
13. Vidal J, Fenollosa P, Martin E, Barberá J, Robaina FJ, Fuentes M, et al. Safety and efficacy of intrathecal baclofen infusion by implantable pump for the treatment of severe spinal spasticity: a spanish multicenter study. Neuromodulation. 2000; 3:175–82.
14. Phillips MM, Miljkovic N, Ramos-Lamboy M, Moossy JJ, Horton J, Buhari AM, et al. Clinical experience with continuous intrathecal baclofen trials prior to pump implantation. PM R. 2015; 7:1052–8.
15. Ordia JI, Fischer E, Adamski E, Spatz EL. Continuous intrathecal baclofen infusion delivered by a programmable pump for the treatment of severe spasticity following traumatic brain injury. Neuromodulation. 2002; 5:103–7.
16. Saulino M, Ivanhoe CB, McGuire JR, Ridley B, Shilt JS, Boster AL. Best practices for intrathecal baclofen therapy: patient selection. Neuromodulation. 2016; 19:607–15.
17. Maneyapanda MB, McCormick ZL, Marciniak C, Reger C. Long-term dosing of intrathecal baclofen in the treatment of spasticity after acquired brain injury. PM R. 2017; 9:556–62.
18. Sansone JM, Mann D, Noonan K, Mcleish D, Ward M, Iskandar BJ. Rapid progression of scoliosis following insertion of intrathecal baclofen pump. J Pediatr Orthop. 2006; 26:125–8.
19. Lins LAB, Nechyporenko AV, Halanski MA, Hetzel SJ, Noonan KJ. Does an intrathecal baclofen pump impact scoliosis progression and complicate posterior spine fusion in patients with cerebral palsy? Spine Deform. 2020; 8:115–21.
20. Walker KR, Novotny SA, Krach LE. Does intrathecal baclofen therapy increase prevalence and/or progression of neuromuscular scoliosis? Spine Deform. 2017; 5:424–9.
21. Rushton PRP, Nasto LA, Aujla RK, Ammar A, Grevitt MP, Vloeberghs MH. Intrathecal baclofen pumps do not accelerate progression of scoliosis in quadriplegic spastic cerebral palsy. Eur Spine J. 2017; 26:1652–7.
22. Shilt JS, Lai LP, Cabrera MN, Frino J, Smith BP. The impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsy. J Pediatr Orthop. 2008; 28:684–7.
23. Lee S, Hyun C, Kim K, Kwon HE, Woo M, Koh SE. Effect of intrathecal baclofen pump on scoliosis in children with cerebral palsy: a meta-analysis. Ann Rehabil Med. 2023; doi: 10.5535/arm.22108 [Epub ahead of print].
24. Burn SC, Zeller R, Drake JM. Do baclofen pumps influence the development of scoliosis in children? J Neurosurg Pediatr. 2010; 5:195–9.
25. Lee BK. Influence of the proprioceptive neuromuscular facilitation exercise programs on idiopathic scoliosis patient in the early 20s in terms of curves and balancing abilities: single case study. J Exerc Rehabil. 2016; 12:567–74.
26. Willson LR, Rogers LG, Gingrich N, Shearer K, Hryniuk SS. Meeting the needs of parents of children with scoliosis: a qualitative descriptive study. Glob Qual Nurs Res. 2021; 8:23333936211045058.
Full Text Links
  • ARM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr